Relevant news






Source: Emirates Biotech
With an exceptional history of successfully executing innovative yet complex industrial projects, SAMSUNG E&A has been appointed as the sole partner for this endeavor. In this capacity, SAMSUNG E&A will manage all engineering, procurement, and construction activities for the Falcon PLA project, ensuring that everything runs smoothly and adheres to the established timeline and budget. The pre-EPC contract, which marks the beginning of this partnership, was signed on April 14, 2025, at Emirates Biotech’s headquarters in the UAE.
Selecting SAMSUNG E&A as our contractor is another significant step toward making our vision a reality. With their extensive expertise in delivering world-class engineering projects, we are confident that this collaboration will ensure the seamless integration of technology into our PLA production facility. The Falcon PLA Project will not only set new benchmarks for scale and efficiency but will also play a key role in providing industries with a viable, sustainable alternative to fossil-based plastics. As we move closer to construction, we are excited to see our plans take shape and contribute to the global shift toward a circular economy.
Marc Verbruggen, CEO of Emirates Biotech
Recently, Emirates Biotech also appointed Sulzer as the technology provider for its PLA facility, and SAMSUNG E&A will ensure the seamless integration of Sulzer's technology and proprietary equipment into the production plant.
Scheduled to commence operations in early 2028, the plant will be situated in the KEZAD free zone in Abu Dhabi, a newly developed industrial area equipped with advanced transportation infrastructure, including the Khalifa deep-sea port.
With our extensive project experience and advanced design technology, we continue to achieve outstanding results in high-value engineering. We are honored that Emirates Biotech has entrusted us with the Falcon PLA Project, and are fully committed to delivering it successfully. SAMSUNG E&A is honored to expand its customer base and enter a new market. This achievement strengthens its competitive position for future projects with Emirates Biotech, marking its entry into the growing eco-friendly plastics sector.
Hong Namkoong, President and CEO of SAMSUNG E&A
Emirates Biotech is committed to accelerating the shift from fossil-based plastics to renewable, biodegradable alternatives, ensuring that industries globally can access high-performance, environmentally responsible solutions.





